Latest Headlines
-
Clarapath Forms Strategic Collaboration With Mayo Clinic To Advance Pathology Tissue Processing
4/23/2024
Clarapath, a medical robotics company transforming the way pathology laboratories process tissue, announced it has entered into a strategic collaboration with Mayo Clinic to propel a new era of laboratory automation.
-
Sapio Sciences Launches New Multimodal Registration Capabilities For Its Lab Informatics Platform
4/23/2024
Sapio Sciences, the science-aware lab informatics platform, today announced the launch of its new multimodal registration capabilities.
-
Copia Scientific Enters Agreement With Leading Pharmaceutical Company
4/23/2024
Copia Scientific, a provider of laboratory equipment and service solutions, is pleased to announce that it has entered into a strategic agreement with a top 10 global Fortune 50 pharmaceutical company.
-
Multiply Labs And GenScript Biotech Corporation Collaborate To Automate The Cell Isolation And Enrichment Phase Of Cell Therapy Manufacturing
4/23/2024
GenScript Biotech Corporation (GenScript), one of the world's leading providers of life-science research tools and services, and Multiply Labs, a robotics company developing industry-leading automated manufacturing systems to produce individualized drugs, today announced a strategic partnership around the automation of the cell isolation phase of cell therapy manufacturing, reducing the complexity of this laborious process.
-
Labconnect Acquires Scientific Consultancy A4P
4/22/2024
LabConnect has announced the acquisition of A4P Consulting Ltd (A4P), a scientific consultancy company, specializing in bioanalytical and biosample project management, biomarker strategy and logistics solutions in support of pre-clinical and clinical trials.
-
Quest Diagnostics Adds p-tau217 Blood Biomarker Testing To Suite Of Services Designed To Assess Risk And Help Aid Diagnosis Of Alzheimer's Disease
4/22/2024
Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today announced the launch of a new blood biomarker test for phosphorylated tau 217, or p-tau217. P-tau217 is a biomarker associated with Alzheimer's Disease (AD), supported by research as useful for an early diagnosis of AD.
-
MGI Tech Opens Customer Experience Center In Brazil To Contribute To The Advancement Of Genomics In Latin America
4/19/2024
Contributing to the advancement of genomics in Latin America, MGI Tech Co. Ltd. (MGI), a company committed to building core tools and technology to lead life science, announced the launch of its Customer Experience Center (CEC) in Brazil.
-
Medline Adds Epredia To Lab Portfolio
4/17/2024
Medline, a market-leading manufacturer and supplier of medical supplies and solutions, is pleased to announce that it is now a direct distributor for Epredia, a member of PHC Group.
-
SOPHiA GENETICS Announces Unilabs Is Using Its AI Technology To Detect Homologous Recombination Deficiency (HRD)
4/17/2024
SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced that Unilabs, one of the largest diagnostic providers in Europe, and the only provider to offer laboratory, imaging and pathology specialties within one group, is live on the SOPHiA DDM™ Platform.
-
Waters Launches Alliance iS Bio HPLC System To Help Biopharma QC Labs Increase Efficiency And Reduce Errors
4/16/2024
Waters Corporation (NYSE:WAT) today announced the launch of the Alliance iS Bio HPLC System with new capabilities that address the operational and analytical challenges of biopharma quality control (QC) laboratories.